Beauty Health (SKIN) to Release Earnings on Thursday

Beauty Health (NASDAQ:SKIN) is expected to be issuing its Q4 2025 results after the market closes on Thursday, March 12th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $78.0650 million for the quarter. Interested persons can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, March 12, 2026 at 4:30 PM ET.

Beauty Health Stock Performance

Shares of NASDAQ SKIN opened at $1.10 on Thursday. The stock has a market cap of $140.25 million, a PE ratio of -5.00 and a beta of 1.20. Beauty Health has a 1 year low of $0.78 and a 1 year high of $2.69. The firm has a fifty day moving average price of $1.31 and a 200-day moving average price of $1.56. The company has a debt-to-equity ratio of 5.53, a current ratio of 4.98 and a quick ratio of 4.07.

Analyst Ratings Changes

A number of brokerages have issued reports on SKIN. Wall Street Zen lowered Beauty Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. TD Cowen upped their price objective on Beauty Health from $1.50 to $1.65 and gave the stock a “hold” rating in a research note on Wednesday, January 21st. Zacks Research downgraded Beauty Health from a “hold” rating to a “strong sell” rating in a research note on Wednesday, January 21st. Finally, Jefferies Financial Group reissued a “hold” rating and issued a $1.60 price target on shares of Beauty Health in a report on Wednesday, January 14th. One investment analyst has rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, Beauty Health has a consensus rating of “Reduce” and an average price target of $2.40.

Institutional Investors Weigh In On Beauty Health

A number of hedge funds have recently made changes to their positions in the company. Invesco Ltd. boosted its stake in Beauty Health by 6.6% during the second quarter. Invesco Ltd. now owns 98,427 shares of the company’s stock valued at $188,000 after buying an additional 6,059 shares during the last quarter. Rhumbline Advisers raised its stake in Beauty Health by 5.7% during the third quarter. Rhumbline Advisers now owns 150,124 shares of the company’s stock valued at $299,000 after purchasing an additional 8,142 shares in the last quarter. The Manufacturers Life Insurance Company grew its stake in shares of Beauty Health by 33.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 41,488 shares of the company’s stock worth $79,000 after buying an additional 10,410 shares in the last quarter. Public Employees Retirement System of Ohio bought a new stake in shares of Beauty Health in the 3rd quarter worth about $26,000. Finally, Franklin Resources Inc. purchased a new stake in shares of Beauty Health during the 3rd quarter valued at about $31,000. 93.26% of the stock is currently owned by hedge funds and other institutional investors.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.